Nanomedicine News

RSS

New Report on Leaders in Smart Pills Technologies Market

Research and Markets has announced the addition of the "Smart Pills Technologies Market (2012-2017) (Diagnostic imaging, patient monitoring, drug delivery)" report to their offering.

From Research and Markets 21 Jun 2013

Undergraduate Nanobiotechnology Researchers Receive Research Fellowship

Collagen, Raman-tweezers and nanotechnology are all well-known words for three Appalachian State University undergraduate physics majors.

21 Jun 2013

CNSE and Nuclea Partner to Develop Nanochips for Cancer Diagnosis and Treatment

Underscoring the strategic blueprint of Governor Andrew M. Cuomo in fueling New York’s growing reputation as a hub for nanotechnology-enabled innovation, SUNY’s College of Nanoscale Science and Engineering (CNSE) and Pittsfield, Massachusetts-based Nuclea Biotechnologies, Inc. (Nuclea) today announced the launch of a $1 million research partnership to enable the development and commercialization of a high-throughput nanochip to accelerate the diagnosis and treatment of breast, colon, prostate and other cancers.

From College of Nanoscale Science and Engineering, University at Albany 21 Jun 2013

Intezyne Technologies Acquires Niiki Pharma

Intezyne Technologies, a privately held drug development company dedicated to improving the treatment of cancer, announced it has acquired Niiki Pharma, of Hoboken, NJ, and Philadelphia, PA. Through the acquisition, Intezyne becomes a development-stage company with two compounds in early and mid-stage clinical development.

20 Jun 2013

Chemical Nanoengineering Innovation Holds Potential to Develop Light-Regulated Therapeutic Molecules

The scientific cooperation between chemists, biotechnologists and physicists from various Catalan institutes, headed by Pau Gorostiza, from the Institute for Bioengineering of Catalonia (IBEC), and Ernest Giralt, from the Institute for Research in Biomedicine (IRB Barcelona), has led to a breakthrough that will favor the development of light-regulated therapeutic molecules.

19 Jun 2013

Comprehensive Report on US Nanotechnology Drug Delivery Market

Research and Markets has announced the addition of the "Nanotechnology Drug Delivery Market in the US 2012-2016" report to their offering.

From Research and Markets 19 Jun 2013

Researchers Carve Nano-Volcanoes Using Light

Researchers from North Carolina State University have developed a method for creating “nano-volcanoes” by shining various colors of light through a nanoscale “crystal ball” made of a synthetic polymer. These nano-volcanoes can store precise amounts of other materials and hold promise for new drug-delivery technologies.

From North Carolina State University 15 Jun 2013

ANSM Approves Nanobiotix’s NBTXR3 Clinical Trial for Advanced Cancers

NANOBIOTIX, a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announces today that its lead compound NBTXR3 has received authorization from the French Medicine Agency, ANSM, to start a clinical trial in patients with locally advanced cancers of the oral cavity or oropharynx (head and neck cancer), at the Institut Curie, Paris, France, a French leading cancer treatment center.

From Nanobiotix 14 Jun 2013

Tufts Nanomedicine Researcher Named Pew Scholar

Qiaobing Xu, assistant professor of biomedical engineering at Tufts University School of Engineering, was named a Pew Scholar in Biomedical Sciences by the Pew Charitable Trusts.

14 Jun 2013